1,3,5-三(1H-四氮唑-5-基)苯 CAS号: 193614-99-2 英文名: 1,3,5-tri(1H-tetrazol-5-yl) benzene 英文别名: 1,3,5-Tris(2H-tetrazol-5-yl)benzene;1,3,5-Tri(2H-tetrazol-5-yl)benzene;1,3,5-tri(1H-tetrazol-5-yl) benzene;1,3,5-tris(1H-tetrazol-5-yl)benzene;5,5',5''-(1,...
英文名称:1,3,5-Tri(1H-tetrazol-5-yl)benzene CAS:193614-99-2 纯度:98% 包装信息:100mg;250mg;1g;5g; 备注:BD01123958 电话询单 吉林中科研伸科技有限公司 联系电话:0431-0431-80514535 19917294565 产品介绍: 英文名称:1,?3,?5-?Tris(2H-?tetrazol-?5-?yl)?benzene CAS:193614-99-2 纯度:96...
基本描述 规格或纯度 97% 英文名称 1,3,5-tris(1H-tetrazol-5-yl)benzene 运输条件 常规运输 名称和识别符 质检证书(COA) 相关文档 溶液计算器服务&支持 客服支持 如何订购? 付款方式 退货政策 大包装询价 质量管理 订单与退货 积分用户手册 危险化学品购买 资源中心 MSDS 质检证书COA 结构式搜索 技术...
Benzene-1,3,5-tricarboxylic acid tris-pyridin-4-ylamide TPBTC 725274-03-3 详细 BENZO[1,2-C:4,5-C']DIPYRROLE-1,3,5,7(2H,6H)-TETRONE, 2,6-DI-4-PYRIDINYL N,N'-双-(4-吡啶基)苯四甲酰亚胺 34072-51-0 详细 4,4',4''-phosphoryltribenzoic acid 三(对羧基苯基)氧化膦 807-19...
Chemical Properties Boiling point959.1±75.0 °C(Predicted) Density1.657±0.06 g/cm3(Predicted) pka4.01±0.10(Predicted) Preparation Products And Raw materials 1,3,5-Triazine-2,4,6-triamine, N2,N4,N6-tris[4-(2H-tetrazol-5-yl)phenyl]- Suppliers...
A soluble, polymeric 5-phenyltetrazolate-bridged Ni(II) complex L. Richards, S.N. Bow, J.L Richards, K. Halton Pages L113-L114 select article Electron perturbing effect of γ-A1203 surface centres on the supported phthalocyaninatocobalt(II) ([Co(pc)]) Short communicationNo access E...
Crystal structure of dicMoro-bis(3(5)-amino-5(3)-methylpyrazole)zinc(II), ZnCl2N6C8H14 Crystal structure of(μз-oxo)-(μз-sulfido)-tris(μ2-(diphenylphosphino)-methane)-tricarbonyl-rhenium-tri-platinum semi(hexafluorophosphate)-semi(tetraoxorhenium)hexane dichloromethane hemisolvate, [Pt3{...
3-((2'-(2H-Tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-3H-benzo[d]imidazole-4-carboxylic acid [CS-VII (Acid) カンデサルタン 139481-59-7 C24H20N6O3 (z)-4-Chloro-2-methoxyimino-3-oxobutyric acid Cefpodoxime Proxetil intermediate 111230-59-2 C5H6ClNO4 2-AMINO-3,5-DIBROMOBENZALD...
Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods inc
, tetrazolyl (e.g., 1H-tetrazolyl, 2H-tetrazolyl, etc.), dihydrotriazinyl (e.g., 4,5-dihydro-1,2,4-triazinyl, 2,5-dihydro-1,2,4-triazinyl, etc.), etc.; saturated 3 to 8-membered heteromonocyclic group containing 1 to 4 nitrogen atom(s), for example, pyrrolidinyl, ...